Clinical Trial Update: 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas [NA]

View source ↗

Summary

Terminated trial evaluating 18F-FDOPA PET/CT or PET/MRI for measuring tumors in patients with newly diagnosed or recurrent gliomas; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma
• Glioma
• Oligodendroglioma

Drugs mentioned

• 18F-FDOPA (fluorodopa (18F))

Snippet

Sponsor: Erik Mittra | Conditions: Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma | NA | Status: TERMINATED | Results posted: 2017-03-20